Baxter International Stock Price, News & Analysis (NYSE:BAX)

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, July 16th. Stockholders of record on Friday, August 30th will be paid a dividend of $0.22 per share on Tuesday, October 1st. This represents a $0.88 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date is Thursday, August 29th. View Baxter International's Dividend History.

Baxter International announced that its board has initiated a share buyback plan on Tuesday, November 13th 2018, which allows the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 6.1% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's board of directors believes its shares are undervalued.

Baxter International Inc (NYSE:BAX) posted its quarterly earnings results on Thursday, July, 25th. The medical instruments supplier reported $0.89 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.81 by $0.08. The medical instruments supplier had revenue of $2.84 billion for the quarter, compared to the consensus estimate of $2.80 billion. Baxter International had a net margin of 14.28% and a return on equity of 21.21%. Baxter International's revenue was down .1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.77 earnings per share. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Baxter International.

Baxter International will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Baxter International updated its FY19 earnings guidance on Thursday, July, 25th. The company provided earnings per share guidance of $3.34-3.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.33. The company issued revenue guidance of $11.24-11.35 billion, compared to the consensus revenue estimate of $11.23 billion.

15 Wall Street analysts have issued 1 year target prices for Baxter International's shares. Their predictions range from $70.00 to $95.00. On average, they expect Baxter International's stock price to reach $85.64 in the next year. This suggests that the stock has a possible downside of 2.7%. View Analyst Price Targets for Baxter International.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Media stories about BAX stock have been trending very negative on Saturday, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Baxter International earned a daily sentiment score of -3.8 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Baxter International.

Baxter International saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 6,470,000 shares, an increase of 32.6% from the August 30th total of 4,880,000 shares. Based on an average trading volume of 2,380,000 shares, the short-interest ratio is currently 2.7 days. Approximately 1.3% of the company's stock are short sold. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ResMed (RMD), Teleflex (TFX), DexCom (DXCM), Insulet (PODD), ABIOMED (ABMD), Novocure (NVCR), Hill-Rom (HRC), Haemonetics (HAE), Integra Lifesciences (IART) and Penumbra (PEN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Honeywell International (HON), Johnson & Johnson (JNJ), Chipotle Mexican Grill (CMG), Micron Technology (MU), Cisco Systems (CSCO), Pfizer (PFE) and Allergan (AGN).

Baxter International's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Robeco Institutional Asset Management B.V. (0.36%), Gateway Investment Advisers LLC (0.06%), Zurcher Kantonalbank Zurich Cantonalbank (0.06%), Envestnet Asset Management Inc. (0.05%), Meyer Handelman Co. (0.05%) and Nisa Investment Advisors LLC (0.04%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Gateway Investment Advisers LLC, Envestnet Asset Management Inc., Robeco Institutional Asset Management B.V., Decatur Capital Management Inc., Stephens Inc. AR, Zurcher Kantonalbank Zurich Cantonalbank, Northpointe Capital LLC and CIBC Private Wealth Group LLC. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was purchased by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., State of Alaska Department of Revenue, Varma Mutual Pension Insurance Co, Meeder Asset Management Inc., TIAA FSB, Pacer Advisors Inc., Cerebellum GP LLC and First Citizens Bank & Trust Co.. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $87.99.

Baxter International has a market capitalization of $44.92 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

The official website for Baxter International is http://www.baxter.com/.

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]